Skip to content
drillr.ai
Sign up

TRDA

Entrada Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$6.75
−2.17%
Ask drillr
0
Insider buys (3m)
33
Insider sells (3m)
-$10.3M
Net value (3m)
-4.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 9, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale38,500$7.11
Sep 9, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale192,500$7.41
Sep 9, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale28,837$7.13
Sep 9, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale28,837$7.13
Sep 9, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale192,500$7.41
Sep 9, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale38,500$7.11
Sep 3, 2026Doshi Dipal · director, officer: CEOF-InKind8,724$7.14
Sep 3, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale29,088$7.06
Sep 3, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale29,088$7.06
Sep 3, 2026Dowden Nathan J · officer: President & COOF-InKind2,528$7.14
Sep 3, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale32,263$7.17
Sep 3, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale25,131$7.19
Sep 3, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale25,131$7.19
Sep 3, 2026WENTWORTH KORY JAMES · officer: Chief Financial OfficerF-InKind1,733$7.14
Sep 3, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale32,263$7.17
Sep 3, 2026Sethuraman Natarajan · officer: President, Research & Develop.F-InKind2,079$7.14
Aug 31, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale38,922$7.20
Aug 31, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale3,733$7.01
Aug 31, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale44,259$6.99
Aug 31, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale38,922$7.20
Aug 31, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale3,733$7.01
Aug 31, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale44,259$6.99
Aug 26, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale21,623$7.34
Aug 26, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale26,522$7.54
Aug 26, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale26,522$7.54
Aug 26, 2026MPM BioVentures 2014, L.P. · 10 percent ownerSale14,569$7.06
Aug 26, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale14,569$7.06
Aug 26, 2026MPM BIOVENTURES 2018, L.P. · 10 percent ownerSale21,623$7.34
Aug 10, 2026PARMAR KUSH · directorSale52,317$6.85
Aug 10, 20265AM Ventures V, L.P. · 10 percent ownerSale52,317$6.85
Institutional positioning

13F filings over the trailing two quarters

New 47Increased 100Reduced 66Sold out 16
FilerActionSharesFiled
BAKER BROS. ADVISORS LPUnchanged5,072,730May 15, 2026
BAKER BROS. ADVISORS LPUnchanged5,072,730Aug 14, 2026
5AM Venture Management, LLCUnchanged4,056,379Aug 14, 2026
5AM VENTURE MANAGEMENT, LLCUnchanged4,056,379May 15, 2026
BlackRock, Inc.Increased2,583,333Aug 7, 2026
BLACKROCK, INC.Increased2,358,793May 13, 2026
TCG CROSSOVER MANAGEMENT, LLCIncreased2,287,500May 15, 2026
Merck & Co., Inc.New Position1,739,768Aug 7, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased1,269,634Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,256,013May 15, 2026
MPM BioImpact LLCNew Position1,253,053Aug 14, 2026
TCG Crossover Management, LLCReduced1,060,230Aug 14, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced1,034,782May 15, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced954,419Aug 14, 2026
MILLENNIUM MANAGEMENT LLCIncreased763,959Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 9, 2026